Cathepsin D-mediated proteolysis of apolipoprotein E: Possible role in Alzheimer’s disease
- 25 September 2006
- journal article
- Published by Elsevier BV in Neuroscience
- Vol. 143 (3), 689-701
- https://doi.org/10.1016/j.neuroscience.2006.08.019
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Spatial patterns of mammalian brain aging: Distribution of cathepsin D–immunoreactive cell bodies and dystrophic dendrites in aging dogs resembles that in Alzheimer's diseaseJournal of Comparative Neurology, 2003
- Expression Analysis of BACE2 in Brain and Peripheral TissuesJournal of Biological Chemistry, 2000
- Novel Cathepsin D Inhibitors Block the Formation of Hyperphosphorylated Tau Fragments in HippocampusJournal of Neurochemistry, 2000
- Apolipoprotein E is essential for amyloid deposition in the APP V717F transgenic mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 1999
- ApoE associated with lipid has a reduced capacity to inhibit β-amyloid fibril formationNeuroReport, 1998
- Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's diseaseBrain Research, 1997
- Cytosolic Proteolysis of τ by Cathepsin D in Hippocampus Following Suppression of Cathepsins B and LJournal of Neurochemistry, 1996
- An immunohistochemical study of cathepsin E in Alzheimer-type dementia brainsBrain Research, 1994
- Antigen processing for presentation by class II major histocompatibility complex requires cleavage by cathepsin EEuropean Journal of Immunology, 1992
- Distribution of cathepsin D immunoreactivity in the central nervous system of rat and selected brain regions of manActa Histochemica, 1985